Pas de connexion internet — affichage de la version enregistrée de la page.

Editas Medicine I…

USUSD
← Vers le screener
US:EDITLSE:0IFK

Editas Medicine Inc (US:EDIT) — Biotechnology: Biological Products (No Diagnostic Substances). Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site web
editasmedicine.com
Relations avec les investisseurs
ir.editasmedicine.com/investor-relations
Secteur
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Siège social
Cambridge, United States
PDG
Dr. Gilmore O'Neill M.D.
Employés
87
Fondée
2013
Actions en circulation
153.58 M au 2026-07-31
Flottant
115.49 M
Capitalisation boursière
397.77 M USD
Initiés
0.18%
Investisseurs institutionnels
79.29%
Secteur d'activité (SIC)
Biological Products, (No Diagnostic Substances)
ISIN
US28106W1036
LEI
5299000AON4Q9NT2JE42
Description

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Bourses et tickers

BourseTickerDevisePrixType
US USA StocksEDIT principaleUSD2.84 +3.27%actions ordinaires
LSE London Stock Exchange0IFK IOBUSD2.5715 +0.00%actions ordinaires

Cours sur 3 mois

jour de hausse jour de baisse date de détachement du dividende date de versementSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Dividendes

Aucun versement de dividendes n'a été trouvé (vérifié le 09.10.2026). L'entreprise ne verse probablement pas de dividendes.

Actualités de cette semaine

Pas encore d'actualités du site de l'entreprise.

publicité

Principaux actionnaires

DétenteurParticipationActionsDate du rapport
TCG Crossover Management…7.23%11.11 M2026-06-30
Blackrock Inc.6.9%10.59 M2026-06-30
Commodore Capital Lp5.79%8.89 M2026-06-30
RA Capital Management, L…5.79%8.89 M2026-06-30
Adar1 Capital Management…5.79%8.89 M2026-06-30
Vanguard Capital Managem…4%6.14 M2026-06-30
Paradigm Biocapital Advi…3.64%5.59 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%4.89 M2026-06-30
Opaleye Management Inc.2.51%3.86 M2026-06-30
Vanguard Portfolio Manag…2.34%3.6 M2026-06-30
Woodline Partners LP2.32%3.56 M2026-06-30
iShares Trust-iShares Ru…1.68%2.58 M2026-07-31
VANGUARD HORIZON FUNDS-V…1.32%2.03 M2026-06-30
VANGUARD INDEX FUNDS-Van…0.72%1.1 M2026-06-30
Fidelity Salem Street Tr…0.71%1.09 M2026-07-31
iShares Trust-iShares Bi…0.69%1.06 M2026-08-31
iShares Trust-iShares Ru…0.55%850 4852026-08-31
Fidelity Concord Street…0.34%522 5842026-07-31
VANGUARD SCOTTSDALE FUND…0.33%505 3062026-05-31
SCHWAB STRATEGIC TRUST-S…0.31%476 3092026-05-31
O NEILL GILMORE NEIL (Ch…≈0.16%243 1892026-09-03
MEI BAISONG (Officer)≈0.09%133 3542024-12-03
LUCERA ERICK J. (Chief F…≈0.07%112 7202025-03-04
BURKLY LINDA (Officer)≈0.04%61 6602026-09-03
PARISON AMY (Chief Finan…≈0.01%13 8392026-09-03